Bolt Biotherapeutics Stock Forecast

Stock Price Forecast

The 3 analysts that cover Bolt Biotherapeutics stock have a consensus rating of "Buy" and an average price target of $34, which forecasts a 648.90% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $75.

Price Target: $34 (+648.90%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.00	$34	$20	$75
Change	+54.19%	+648.90%	+340.53%	+1552.0%

Analyst Ratings

The average analyst rating for Bolt Biotherapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+54.19%	Mar 13, 2026
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $7	Strong Buy	Initiates	$7	+54.19%	Oct 20, 2025
Chad Messer Lake Street	Lake Street	Strong Buy Maintains $4 → $75	Strong Buy	Maintains	$4 → $75	+1,551.98%	Aug 15, 2025
Chad Messer Lake Street	Lake Street	Strong Buy Initiates $80	Strong Buy	Initiates	$80	+1,662.11%	May 20, 2025
Stephen Willey Stifel	Stifel	Hold Maintains $25 → $20	Hold	Maintains	$25 → $20	+340.53%	May 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.38M

from 7.70M

-69.07%

from 7.70M

Revenue Next Year

153.00K

from 2.38M

-93.57%

from 2.38M

EPS This Year

-19.87

from -17.85

EPS Next Year

-20.83

from -19.87

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.26M	5.73M	7.88M	7.69M	7.70M	2.38M	153.00K
Revenue Growth	445.46%	354.68%	37.48%	-2.36%	0.07%	-69.07%	-93.57%
EPS	-59.40	-47.16	-36.60	-33.06	-17.85	-19.87	-20.83
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	6.3M	315,000
Avg	2.4M	153,000
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-18.1%	-86.8%
Avg	-69.1%	-93.6%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-12.63	-1.30
Avg	-19.87	-20.83
Low	-32.76	-38.81

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.